Skip to main content
USAID

USAID's Neglected Tropical Diseases Program
USAID's Neglected Tropical Disease Program

  • NTDs thrive under conditions of poverty, poor sanitation, unsafe water, and malnutrition
  • NTDs can blind, deform, and debilitate their victims
  • NTDs compromise mental and physical development, reduce school enrollment, and hinder economic productivity
  • Preventing NTDs attacks a root cause of poverty that affects a significant proportion of the world’s population
  • Safe and effective drugs are now available to prevent the most common NTDs

About the NTD Program

On May 5, 2009, President Obama announced a new comprehensive global health strategy, which includes a focus on neglected tropical diseases, to address some of the world's biggest health challenges. Learn more.

Latest News

Go to Newsroom
Jan
27

Uniting to Combat Neglected Tropical Diseases

Tune in for a live webcast, Monday, January 30th 2012, featuring Bill Gates, Margaret Chan, 9 pharmaceutical company CEOs, senior government officials and others on the topic of Ending the Neglect and Reaching 2020 Goals. The webcast will air between 11:00-12:30 GMT from London and a recorded version will be available afterwards.
Read More


Dec
14

The Global Network for Neglected Tropical Disease launches End7

The Global Network for Neglected Tropical Diseases' (NTDs) "End The Neglect" blog introduces the Network's "End7" Campaign, which aims to end seven of the most common NTDs by 2020 through public donations to help fund drug delivery in developing countries.
Read More


Dec
13

Merck Serono Helps Eliminate Schistosomiasis in Africa

Merck Serono has announced its intention to further boost its efforts in the fight against the tropical disease schistosomiasis and to continue until the disease has been officially eliminated in Africa. The company plans to double its annual donation of tablets from 25 million to 50 million.
Read More


Oct
21

USAID Awards New Flagship Project “Envision” for Neglected Tropical Diseases

USAID is pleased to announce the award of its new flagship project for neglected tropical diseases to RTI International. The project, Envision, is a five-year Cooperative Agreement, with a $240 million ceiling, which covers the period of October 1, 2011, to September 29, 2016.
Read More


Sept
20

GlaxoSmithKline Gives Update on Agreement with WHO to Support Deworming of School Age Children in Endemic Countries

GlaxoSmithKline today announced progress on its commitment to expand the donation of albendazole to the World Health Organization to treat school age children at risk of intestinal worms, known as soil-transmitted helminths.
Read More